Page last updated: 2024-11-12

decanoylcarnitine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

decanoylcarnitine: therapeutic agent for diabetic acidosis; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

O-decanoylcarnitine : An O-acylcarnitine compound having decanoyl as the acyl substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10245190
CHEMBL ID3559489
CHEBI ID68830
SCHEMBL ID234694
MeSH IDM0043707

Synonyms (31)

Synonym
decanoylcarnitine
vgk89ve61s ,
1-propanaminium, 3-carboxy-n,n,n-trimethyl-2-((1-oxodecyl)oxy)-, inner salt
unii-vgk89ve61s
1492-27-9
3-(decanoyloxy)-4-(trimethylammonio)butanoate
o-decanoylcarnitine
CHEBI:68830 ,
SCHEMBL234694
o-decanoylcarnitine, dl
capryl-dl-carnitine
decanoyl-(+/-)-carnitine
3-decanoyloxy-4-(trimethylazaniumyl)butanoate
(3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt, decanoate
n,n,n-trimethyl-2-(decanoyloxy)-3-carboxylato-1-propaneaminium decanoyl-dl-carnitine
ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, hydroxide, inner salt, decanoate
decanoylcarnitine, (+/-)-
decanoic acid, ester with (3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt
decanoylcar
J3.017.380E ,
decanoyl-dl-carnitine
CHEMBL3559489
LMFA07070059
3-(decanoyloxy)-4-(trimethylazaniumyl)butanoate
acylcarnitine c10:0
Q27137205
(+/-)-decanoylcarnitine
(s)-3-(decanoyloxy)-4-(trimethylammonio)butanoate
1-propanaminium, 3-carboxy-n,n,n-trimethyl-2-[(1-oxodecyl)oxy]-, inner salt
STARBLD0014185
ac(10:0)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
O-acylcarnitineAny carboxylic ester obtained by the O-acylation of carnitine.
decanoate esterA fatty acid ester resulting from the formal condensation of the carboxy group of decanoic acid (capric acid) with the hydroxy group of an alcohol or phenol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID781325pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 20092014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (28.57)18.7374
1990's6 (21.43)18.2507
2000's2 (7.14)29.6817
2010's11 (39.29)24.3611
2020's1 (3.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.60 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.45%)6.00%
Case Studies1 (3.45%)4.05%
Observational1 (3.45%)0.25%
Other26 (89.66%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]